Fig. 7From: Fumigaclavine C ameliorates liver steatosis by attenuating hepatic de novo lipogenesis via modulation of the RhoA/ROCK signaling pathwayScheme of the molecular mechanisms of the hepatoprotective effects of FCBack to article page